Association between Inflammatory Cytokine Levels and Thrombocytopenia during Plasmodium falciparum and P. vivax Infections in South-Western Coastal Region of India.

Q2 Medicine
Malaria Research and Treatment Pub Date : 2019-04-11 eCollection Date: 2019-01-01 DOI:10.1155/2019/4296523
Kishore Punnath, Kiran K Dayanand, Valleesha N Chandrashekar, Rajeshwara N Achur, Srinivas B Kakkilaya, Susanta K Ghosh, Suchetha N Kumari, D Channe Gowda
{"title":"Association between Inflammatory Cytokine Levels and Thrombocytopenia during <i>Plasmodium falciparum</i> and <i>P. vivax</i> Infections in South-Western Coastal Region of India.","authors":"Kishore Punnath,&nbsp;Kiran K Dayanand,&nbsp;Valleesha N Chandrashekar,&nbsp;Rajeshwara N Achur,&nbsp;Srinivas B Kakkilaya,&nbsp;Susanta K Ghosh,&nbsp;Suchetha N Kumari,&nbsp;D Channe Gowda","doi":"10.1155/2019/4296523","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Thrombocytopenia is a most commonly observed complication during malaria infections. Inflammatory cytokines such as IL-1, IL-6, and IL-10 have been documented in malaria induced thrombocytopaenia. This study was aimed to understand the possible relationship between inflammatory cytokines across varying degrees of thrombocytopenia during <i>P. vivax</i>, <i>P. falciparum,</i> and mixed infections.</p><p><strong>Methods: </strong>A hospital-based cross sectional study was conducted at District Wenlock Hospital in Mangaluru, a city situated along the south-western coastal region of Arabian Sea in India. In this study, blood samples from 627 malaria patients were analyzed for infected parasite species, clinical conditions, platelet levels, and key cytokines that are produced in response to infection; samples from 176 uninfected healthy individuals were used as controls.</p><p><strong>Results: </strong>The results of our study showed a high prevalence of malarial thrombocytopenia (platelets <150 ×10<sup>3</sup>/<i>μ</i>l) in this endemic settings. About 62.7% patients had mild-to-moderate levels of thrombocytopenia and 16% patients had severe thrombocytopenia (platelets <50 × 10<sup>3</sup>/<i>μ</i>l). Upon comparison of cytokines across varying degrees of thrombocytopenia, irrespective of infecting species, the levels of TNF-<i>α</i> and IL-10 were significantly higher during thrombocytopenia, whereas IL-6 levels were considerably lower in severe thrombocytopenia patients suffering from <i>P. vivax</i> or <i>P. falciparum</i> infections. The severe clinical complications observed in patients with malarial thrombocytopenia included severe anemia (17.5%), acute renal failure (12.7%), jaundice (27.0%), metabolic acidosis (36.5%), spontaneous bleeding (3.2%), hypoglycemia (25.4%), hyperparasitemia (4.8%), acute respiratory distress syndrome (1.6%), pulmonary edema (19.0%), and cerebral malaria (1.6%) in various combinations.</p><p><strong>Conclusion: </strong>Overall, the results of our study suggest that inflammatory cytokines influence the transformation of mild forms of thrombocytopenia into severe forms during malarial infections. Further studies are needed to understand the association of inflammatory cytokine responses with severe malaria complications and thrombocytopenia.</p>","PeriodicalId":18089,"journal":{"name":"Malaria Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/4296523","citationCount":"18","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malaria Research and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2019/4296523","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 18

Abstract

Background: Thrombocytopenia is a most commonly observed complication during malaria infections. Inflammatory cytokines such as IL-1, IL-6, and IL-10 have been documented in malaria induced thrombocytopaenia. This study was aimed to understand the possible relationship between inflammatory cytokines across varying degrees of thrombocytopenia during P. vivax, P. falciparum, and mixed infections.

Methods: A hospital-based cross sectional study was conducted at District Wenlock Hospital in Mangaluru, a city situated along the south-western coastal region of Arabian Sea in India. In this study, blood samples from 627 malaria patients were analyzed for infected parasite species, clinical conditions, platelet levels, and key cytokines that are produced in response to infection; samples from 176 uninfected healthy individuals were used as controls.

Results: The results of our study showed a high prevalence of malarial thrombocytopenia (platelets <150 ×103/μl) in this endemic settings. About 62.7% patients had mild-to-moderate levels of thrombocytopenia and 16% patients had severe thrombocytopenia (platelets <50 × 103/μl). Upon comparison of cytokines across varying degrees of thrombocytopenia, irrespective of infecting species, the levels of TNF-α and IL-10 were significantly higher during thrombocytopenia, whereas IL-6 levels were considerably lower in severe thrombocytopenia patients suffering from P. vivax or P. falciparum infections. The severe clinical complications observed in patients with malarial thrombocytopenia included severe anemia (17.5%), acute renal failure (12.7%), jaundice (27.0%), metabolic acidosis (36.5%), spontaneous bleeding (3.2%), hypoglycemia (25.4%), hyperparasitemia (4.8%), acute respiratory distress syndrome (1.6%), pulmonary edema (19.0%), and cerebral malaria (1.6%) in various combinations.

Conclusion: Overall, the results of our study suggest that inflammatory cytokines influence the transformation of mild forms of thrombocytopenia into severe forms during malarial infections. Further studies are needed to understand the association of inflammatory cytokine responses with severe malaria complications and thrombocytopenia.

Abstract Image

印度西南沿海地区恶性疟原虫和间日疟原虫感染期间炎症细胞因子水平与血小板减少的关系
背景:血小板减少症是疟疾感染期间最常见的并发症。炎症细胞因子如IL-1、IL-6和IL-10在疟疾引起的血小板减少症中已被证实。本研究旨在了解在间日疟原虫、恶性疟原虫和混合感染期间不同程度血小板减少的炎症因子之间可能的关系。方法:以医院为基础的横断面研究在位于印度阿拉伯海西南沿海地区的城市曼格鲁的文洛克区医院进行。在这项研究中,分析了627名疟疾患者的血液样本,包括感染的寄生虫种类、临床状况、血小板水平和对感染产生的关键细胞因子;来自176名未感染的健康个体的样本作为对照。结果:我们的研究结果显示,疟疾性血小板减少症(血小板3/μl)在该地区的流行率很高。62.7%的患者有轻中度血小板减少,16%的患者有重度血小板减少(血小板3/μl)。通过比较不同程度的血小板减少症患者的细胞因子,无论感染何种物种,TNF-α和IL-10水平在血小板减少症期间显著较高,而IL-6水平在患有间日疟原虫或恶性疟原虫感染的严重血小板减少症患者中显著较低。疟疾性血小板减少患者的严重临床并发症包括严重贫血(17.5%)、急性肾功能衰竭(12.7%)、黄疸(27.0%)、代谢性酸中毒(36.5%)、自发性出血(3.2%)、低血糖(25.4%)、高寄生虫血症(4.8%)、急性呼吸窘迫综合征(1.6%)、肺水肿(19.0%)和脑型疟疾(1.6%)。结论:总的来说,我们的研究结果表明,炎症细胞因子影响疟疾感染期间轻度血小板减少症向严重血小板减少症的转变。需要进一步的研究来了解炎症细胞因子反应与严重疟疾并发症和血小板减少症的关系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Malaria Research and Treatment
Malaria Research and Treatment Medicine-Infectious Diseases
CiteScore
5.20
自引率
0.00%
发文量
0
期刊介绍: Malaria Research and Treatment is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to all aspects of malaria.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信